FMP
NovAccess Global Inc.
XSNX
PNK
NovAccess Global Inc., a biopharmaceutical company, develops novel immunotherapies to treat brain tumor patients in the United States. The company specializes in cutting-edge research related to utilizing a patient's immune system to attack the cancer. NovAccess Global Inc. was incorporated in 1997 and is headquartered in Chesterland, Ohio.
0.0002 USD
0 (0%)
Valuation Date:
Mar 14, 2025 1:19 PM
Share Price on Valuation Date
$0
Stock Beta
1.894
Shares Outstanding
61906900